Magazine article from our research archive:

Market Watch: DRUG DEVELOPMENT

A recent survey conducted by Bearing Point and AMR Research found that 26% of more than 100 pharmaceutical and biotech executives surveyed expect to conduct 21 or more Phase I studies per year by 2010, an 18% increase from 2007. The survey also revealed significant growth in global trials, with Africa, the Middle East, Eastern Europe, and South America topping the list of regional expansion. Additional key findings:

* More than 57% of survey respondents anticipate increasing or maintaining the number of subjects participating in ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!